Founded in 2018, Cellagility Biomed Private Limited is building a capability within the Bangalore Bioinnovation Centre to complete the first milestone, a Proof Of Concept (POC) delivering safe and standardised clinical grade iPSCs lines. The company is based on collaboration with Japanese scientific knowhow, production in Bangalore and British quality assurance. Cellagility Biomed Private Limited has already derived the company’s first pilot cell line, a project that was successfully driven by Arun MG Kumar, Technical Operations Manager at Kyoto University, Japan. The POC will confirm the company’s capability to supply safe viable and affordable iPSC lines, opening a future supply chain for ethically sourced cells in Bangalore.

Our mission is the delivery of ethically-approved, quality-controlled safe stem cell lines for medical research and treatment.